FUSEN PHARM (01652) announced that the new drug application for "Glucosamine Sulfate Capsules" (brand name: Shu Hui Tong), developed by its wholly-owned subsidiary Henan FUSEN Pharmaceutical Co., Ltd., has been approved by the China National Medical Products Administration. The capsules are approved for the treatment of both primary and secondary osteoarthritis. Glucosamine Sulfate is a natural amino monosaccharide and an essential substance for the synthesis of human joint cartilage matrix. As a joint cartilage protective agent, it can alleviate joint pain, improve joint function, repair cartilage, strengthen joints, and promote the repair and reconstruction of the cartilage matrix, thereby delaying the pathological process of osteoarthritis and improving joint mobility while relieving pain. Osteoarthritis is a degenerative disease associated with factors such as age, body weight, and joint wear. It is characterized by a long disease course and a tendency to recur. Patients require not only short-term pain relief but also long-term maintenance of joint function, a need which Glucosamine Sulfate Capsules are designed to address.